NEUMORA THERAPEUTICS, INC. Share Price Today: Live Updates & Key Insights
NEUMORA THERAPEUTICS, INC. share price today is $2.5, up -2.33%. The stock opened at $2.53 against the previous close of $2.57, with an intraday high of $2.625 and low of $2.5.
NEUMORA THERAPEUTICS, INC. Share Price Chart
NEUMORA THERAPEUTICS, INC.
NEUMORA THERAPEUTICS, INC. Share Price Performance
NEUMORA THERAPEUTICS, INC. Institutional Holdings
NEUMORA THERAPEUTICS, INC. Market Status
NEUMORA THERAPEUTICS, INC. Fundamentals
Market Cap 426.55 M
PB Ratio 3.3046
PE Ratio 0.0
Enterprise Value 285.30 M
Total Assets 316.97 M
Volume 625007
NEUMORA THERAPEUTICS, INC. Company Financials
About NEUMORA THERAPEUTICS, INC. & investment objective
Company Information Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Organisation Biotechnology
Employees 95
Industry Biotechnology
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
NEUMORA THERAPEUTICS, INC. FAQs
What is the share price of NEUMORA THERAPEUTICS, INC. today?
The current share price of NEUMORA THERAPEUTICS, INC. is $2.5.
Can I buy NEUMORA THERAPEUTICS, INC. shares in India?
Yes, Indian investors can buy NEUMORA THERAPEUTICS, INC. shares by opening an international trading and demat account with Motilal Oswal.
How to buy NEUMORA THERAPEUTICS, INC. shares in India?
You can easily invest in NEUMORA THERAPEUTICS, INC. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy NEUMORA THERAPEUTICS, INC. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of NEUMORA THERAPEUTICS, INC..
Can I buy fractional shares of NEUMORA THERAPEUTICS, INC.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of NEUMORA THERAPEUTICS, INC.?
NEUMORA THERAPEUTICS, INC. has a market cap of $426.55 M.
In which sector does NEUMORA THERAPEUTICS, INC. belong?
NEUMORA THERAPEUTICS, INC. operates in the Biotechnology sector.
What documents are required to invest in NEUMORA THERAPEUTICS, INC. stocks?
To invest, you typically need:
What is the PE and PB ratio of NEUMORA THERAPEUTICS, INC.?
The PE ratio of NEUMORA THERAPEUTICS, INC. is N/A and the PB ratio is 3.30.